Share Email Print
cover

Proceedings Paper

New laser sources for clinical treatment and diagnostics of neonatal jaundice
Author(s): Mostafa Hamza; Mohammad Hamza Sayed El-Ahl; Ahmad Mohammad Hamza
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

An elevated serum bilirubin concentration in the newborn infant presents a therapeutic as well as a diagnostic problem to the physician. It has long been recognized that high levels of bilirubin cause irreversible brain damage and even death. The authors introduce the use of semiconductor diode lasers and diode-pumped solid-state lasers that can be used for solving such diagnostic and therapeutic problems. These new laser sources can improve the ergonomics of using laser, enhance performance capabilities and reduce the cost of employing laser energy to pump bilirubin out of an infant's body. The choice of laser wavelengths follows the principles of bilirubinometry and phototherapy of neonatal jaundice. The wide spread use of these new laser sources for clinical monitoring and treatment of neonatal hyperbilirubinemia will be made possible as each incremental or quantum jump cost reduction is achieved. Our leading clinical experience as well as the selection rules of laser wavelengths will be presented.

Paper Details

Date Published: 4 June 2001
PDF: 7 pages
Proc. SPIE 4254, Biomedical Diagnostic, Guidance, and Surgical-Assist Systems III, (4 June 2001); doi: 10.1117/12.427933
Show Author Affiliations
Mostafa Hamza, Mansoura Univ. (Egypt)
Mohammad Hamza Sayed El-Ahl, Military Medical Academy (Egypt)
Ahmad Mohammad Hamza, Tabarak Children's Hospital (Egypt)


Published in SPIE Proceedings Vol. 4254:
Biomedical Diagnostic, Guidance, and Surgical-Assist Systems III
Tuan Vo-Dinh; Warren S. Grundfest; David A. Benaron, Editor(s)

© SPIE. Terms of Use
Back to Top